Xu, B., Zhang, Q., Luo, Y., Tong, Z., Sun, T., Shan, C., Liu, X., Yao, Y., Zhao, B., Wang, S., Zeng, X., Hu, C., Yan, X., Wang, X., Jia, H., Chen, Z., Qiu, F., Wu, X., Zhang, D., Li, T. (2025). Lerociclib plus fulvestrant in patients with HR+/HER2− locally advanced or metastatic breast cancer who have progressed on prior endocrine therapy: LEONARDA-1 a phase III randomized trial. Nature Communications. https://doi.org/10.1038/s41467-025-56096-2